Neural correlates of donepezil-induced cognitive improvement in patients with right hemisphere stroke: A pilot study

Neuropsychological Rehabilitation

Volumn 21, Issue 4, 2011, Pages 502-514

  Chang, Won Hyuk ^a   Park, Yun H ^a   Ohn, Suk Hoon ^b   Park, Chang Hyun ^a   Lee, Peter K W ^a   Kim, Yun Hee ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Hallym University   (South Korea)

Author keywords

Cognitive impairment; Donepezil; functional MRI; Stroke

Indexed keywords

DONEPEZIL; INDAN DERIVATIVE; NOOTROPIC AGENT; PIPERIDINE DERIVATIVE;

ADULT; AGED; ARTICLE; BRAIN MAPPING; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEMISPHERIC DOMINANCE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NERVE TRACT; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; PILOT STUDY; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; STATISTICS; STROKE;

ADULT; AGED; BRAIN MAPPING; COGNITION DISORDERS; FEMALE; FUNCTIONAL LATERALITY; HUMANS; INDANS; MALE; MIDDLE AGED; NEURAL PATHWAYS; NEUROPSYCHOLOGICAL TESTS; NOOTROPIC AGENTS; PILOT PROJECTS; PIPERIDINES; STROKE;

EID: 80051705373     PISSN: 09602011     EISSN: 14640694     Source Type: Journal    
DOI: 10.1080/09602011.2011.582708     Document Type: Article

References (25)

1. Ballard, C., Stephens, S., McLaren, A., Wesnes, K., & Kenny, R. (2003). Mild cognitive impairment and vascular cognitive impairment in stroke patients. International Psychogeriatrics, 15(Suppl 1), 123-126. (Pubitemid 37175178)
2. Berthier, M. L. (2005). Poststroke aphasia: Epidemiology, pathophysiology and treatment. Drugs and Aging, 22(2), 163-182. (Pubitemid 40445325)
3. Berthier, M. L., Hinojosa, J., Martin Mdel, C., & Fernandez, I. (2003). Open-label study of donepezil in chronic poststroke aphasia. Neurology, 60(7), 1218-1219. (Pubitemid 36418800)
4. Black, S., Roman, G. C., Geldmacher, D. S., Salloway, S., Hecker, J., Burns, A., et al. (2003). Efficacy and tolerability of donepezil in vascular dementia: Positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke, 34(10), 2323-2330. (Pubitemid 37221934)
5. Boivin, M. J., Giordani, B., Berent, S., Amato, D. A., Lehtinen, S., Koeppe, R. A., et al. (1992). Verbal fluency and positron emission tomographic mapping of regional cerebral glucose metabolism. Cortex, 28(2), 231-239.
6. Court, J. A., Perry, E. K., & Kalaria, R. N. (2002). Neurotransmitter control of the cerebral vasculature and abnormalities in vascular dementia. In T. Erkinjuntti, & S. Gauthier (Eds.), Vascular Cognitive Impairment. London: Martin Dunitz.
7. Cummings, J. L., Donohue, J. A., & Brooks, R. L. (2000). The relationship between donepezil and behavioral disturbances in patients with Alzheimer's disease. American Journal of Geriatric Psychiatry, 8(2), 134-140. (Pubitemid 30226963)
8. Esposito, G., Kirkby, B. S., Van Horn, J. D., Ellmore, T. M., & Berman, K. F. (1999). Context-dependent, neural system-specific neurophysiological concomitants of ageing: Mapping PET correlates during cognitive activation. Brain, 122(Pt 5), 963-979. (Pubitemid 29219268)
9. Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189-198.
10. Gottfries, C. G., Blennow, K., Karlsson, I., & Wallin, A. (1994). The neurochemistry of vascular dementia. Dementia, 5(3-4), 163-167. (Pubitemid 24151539)
11. Gray, J. R., Chabris, C. F., & Braver, T. S. (2003). Neural mechanisms of general fluid intelligence. Nature Neuroscience, 6(3), 316-322. (Pubitemid 36278291)
12. Gray, J. R., & Thompson, P. M. (2004). Neurobiology of intelligence: Science and ethics. Nature Reviews Neuroscience, 5(6), 471-482. (Pubitemid 38715514)
13. Kim, Y. H., Shin, S. H., Park, S. H., & Ko, M. H. (2001). Cognitive assessment for patient with brain injury by computerized neuropsychological test. Journal of Korean Academy of Rehabilitation Medicine, 25(2), 209-216.
14. Lee, K. H., Choi, Y. Y., Gray, J. R., Cho, S. H., Chae, J. H., Lee, S., et al. (2006). Neural correlates of superior intelligence: Stronger recruitment of posterior parietal cortex. Neuroimage, 29(2), 578-586. (Pubitemid 43063314)
15. Masanic, C. A., Bayley, M. T., VanReekum, R., & Simard, M. (2001). Open-label study of donepezil in traumatic brain injury. Archives of Physical Medicine and Rehabilitation, 82(7), 896-901. (Pubitemid 32619812)
16. Mesulam, M., Siddique, T., & Cohen, B. (2003). Cholinergic denervation in a pure multi-infarct state: Observations on CADASIL. Neurology, 60(7), 1183-1185. (Pubitemid 36418785)
17. Robertson, I. H., & Murre, J. M. (1999). Rehabilitation of brain damage: Brain plasticity and principles of guided recovery. Psychological Bulletin, 125(5), 544-575.
18. Rogers, S. L., Farlow, M. R., Doody, R. S., Mohs, R., & Friedhoff, L. T. (1998). A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group. Neurology, 50(1), 136-145.
19. Roman, G. C., & Kalaria, R. N. (2006). Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia. Neurobiology of Aging, 27(12), 1769-1785. (Pubitemid 44572575)
20. Somerville, J., Tremont, G., & Stern, R. A. (2000). The Boston Qualitative Scoring System as a measure of executive functioning in Rey-Osterrieth Complex Figure performance. Journal of Clinical and Experimental Neuropsychology, 22(5), 613-621.
21. Starkstein, S. E., Fedoroff, J. P., Price, T. R., Leiguarda, R., & Robinson, R. G. (1993). Apathy following cerebrovascular lesions. Stroke, 24(11), 1625-1630. (Pubitemid 23315865)
22. Swartz, R. H., Sahlas, D. J., & Black, S. E. (2003). Strategic involvement of cholinergic pathways and executive dysfunction: Does location of white matter signal hyperintensities matter? Journal of Stroke and Cerebrovascular Diseases, 12(1), 29-36. (Pubitemid 36292855)
23. Taverni, J. P., Seliger, G., & Lichtman, S. W. (1998). Donepezil medicated memory improvement in traumatic brain injury during post acute rehabilitation. Brain Injury, 12(1), 77-80. (Pubitemid 28033504)
24. Vinters, H. V., Ellis, W. G., Zarow, C., Zaias, B. W., Jagust, W. J., Mack, W. J., et al. (2000). Neuropathologic substrates of ischemic vascular dementia. Journal of Neuropathology and Experimental Neurology, 59(11), 931-945.
25. Wilkinson, D., Doody, R., Helme, R., Taubman, K., Mintzer, J., Kertesz, A., et al. (2003). Done-pezil in vascular dementia: A randomized, placebo-controlled study. Neurology, 61(4), 479-486. (Pubitemid 37025364)